CellaVision AB (publ) (FRA:C26)

Germany flag Germany · Delayed Price · Currency is EUR
16.38
-0.14 (-0.85%)
Last updated: Oct 21, 2025, 8:03 AM CET
-0.85%
Market Cap408.51M
Revenue (ttm)67.29M
Net Income (ttm)13.54M
Shares Outn/a
EPS (ttm)0.57
PE Ratio30.18
Forward PE25.19
Dividend0.23 (1.41%)
Ex-Dividend DateMay 7, 2025
Volumen/a
Average Volume303
Open16.38
Previous Close16.52
Day's Range16.38 - 16.38
52-Week Range13.10 - 24.70
Betan/a
RSI55.01
Earnings DateNov 6, 2025

About CellaVision AB

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1994
Employees 219
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C26
Full Company Profile

Financial Performance

In 2024, CellaVision AB's revenue was 723.22 million, an increase of 6.78% compared to the previous year's 677.29 million. Earnings were 140.72 million, an increase of 7.99%.

Financial numbers in SEK Financial Statements

News

3 Scandinavian Companies With Strong Margin Growth

According to the All-in-One Screener, a Premium feature of GuruFocus, three Scandinavian companies with strong margin growth as of Monday are CellaVision AB (OSTO:CEVI), Fenix Outdoor International Lt...

5 years ago - GuruFocus